ADVERTISEMENT
News
Antibiotic Tumescent for Chronic Wounds
04/01/2024
A Phase II 60-patient RCT will examine the safety of subcutaneous tumescent antibiotic administration and compare with SoC for the treatment of chronic wounds with primary outcome of rate of occurrence and severity of adverse events up to 6 months. Estimated study completion is 3/28. clinicaltrials.gov
